“…In the granular dentate gyrus and pyramidal CA1–CA3, M 2 mAChRs are located in inhibitory GABAergic presynaptic terminals, whereas M 1 and M 4 mAChRs are distributed in the somatodendritic compartment of pyramidal neurons. The increase in cortical M 2 mAChR may indicate a secondary regulation of cortical M 2 mAChR, which is consistent with previous studies. ,− Regarding the modulation of hippocampal cholinergic signaling, lesions directed at the medial septum-vertical diagonal band complex have demonstrated a decrease in both density and activity of mAChR, revealing completely opposite effects to those observed when the NBM is lesioned. − The absence of nonspecific damage to the SM-vertical diagonal band complex indicates that the increase in M 2 /M 4 mAChR-mediated signaling in the hippocampus should also be considered as a secondary modulation of muscarinic signaling. In the hippocampus, M 2 mAChR inhibits ACh release, while M 1 mAChR potentiates glutamatergic signaling. ,− Moreover, mice lacking M 2 mAChR showed deficits in learning during avoidance and spatial memory tests, demonstrating the role of this receptor subtype in cognitive processes which are dependent on both short- and long-term potentiation and completely reversed with GABA A receptor antagonists. , Therefore, the immunotoxin-induced increase in hippocampal muscarinic functionality mediated by M 2 mAChR could be decreasing the GABAergic tone and increasing glutamatergic transmission as a compensatory mechanism following the lesion of the NBM, contributing to the so-called “muscarinic long-term potentiation”, which is essential to explain hippocampal neuronal plasticity …”